Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (6.098%)
Market Cap: £85.91m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Statement re Possible Offer

23 Oct 2025 16:32

RNS Number : 6345E
Inspecs Group PLC
23 October 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS IS AN ANNOUNCEMENT OF A POSSIBLE OFFER UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE NOR AS TO THE TERMS OF ANY OFFER IF MADE

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

23 October 2025

 

Inspecs Group PLC ("Inspecs", or the "Company")

 

Statement regarding possible offer

 

 

The Board of Inspecs notes the recent press speculation and confirms that it has received two separate, unsolicited proposals from H2 Equity Partners Ltd. ("H2"), and Risk Capital Partners and Ian Livingstone (together, the "Consortium"), each setting out non-binding possible cash offers alongside the possibility of an alternative offer including unlisted securities to acquire the entire issued and to be issued share capital of Inspecs. The Company also received on 21 October a proposal from Safilo Group S.p.A ("Safilo") to acquire the Eschenbach Group and BoDe businesses of Inspecs.

 

There can be no certainty that an offer will be made, nor as to the terms of any offer if made. A further announcement will be made if and when appropriate.

 

In accordance with Rule 2.6(a) of the Code, each of H2 and the Consortium is required, by not later than 5.00 p.m. (London time) on 20 November 2025, either to announce a firm intention to make an offer for Inspecs in accordance with Rule 2.7 of the Code, or to announce that it does not intend to make an offer for Inspecs, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can only be extended with the consent of the Panel on Takeovers and Mergers in accordance with Rule 2.6(c) of the Code.

 

This announcement is being made by Inspecs without the consent of H2, the Consortium or Safilo.

 

Enquiries:

 

Inspecs Group plc

Via FTI Consulting

Peel Hunt LLP (Financial Adviser, NOMAD and Broker)

+44 (0) 20 7418 8900

 

George Sellar

 

Michael Nicholson

 

Andrew Clark

 

 

FTI Consulting (Financial PR) 

+44 (0) 20 3727 1000

 

Alex Beagley

 

Harriet Jackson

 

Amy Goldup

 

 

 

 

Important information

 

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as financial adviser and corporate broker to Inspecs and for no one else in connection with the matters referred to in this announcement and will not be responsible to any person other than Inspecs for providing the protections afforded to clients of Peel Hunt, nor for providing advice in relation to the matters referred to herein. Neither Peel Hunt nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Peel Hunt in connection with the matters referred to in this announcement, or otherwise.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018). Upon publication of this announcement, this inside information will be considered to be in the public domain. The person responsible for arranging the release of this announcement on behalf of the Company is Elliott Smith, General Counsel & Company Secretary.

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise. Any offer, if made, will be made solely by certain offer documentation, which will contain the full terms and conditions of any offer, including details of how it may be accepted.

 

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom and the availability of any offer to shareholders of Inspecs who are not resident in the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of Inspecs who are not resident in the United Kingdom will need to inform themselves about, and observe, any applicable requirements. Any failure to comply with such requirements may constitute a violation of the securities law of any such jurisdiction.

 

Disclosure requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4). Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

Rule 26.1 disclosure

 

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) at www.Inspecs.com/investor-relations by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Rule 2.9 information

 

In accordance with Rule 2.9 of the Code, the Company confirms that as at the close of business on 22 October 2025 its issued share capital consisted of 101,671,525 ordinary shares of 1 pence each.

 

The Ordinary Shares are voting shares (each such Ordinary Share carries one vote per Ordinary Share) and are admitted to trading on the main market of the London Stock Exchange under the International Securities Identification Number GB00BK6JPP03.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDFLFVEIILVFIE
Date   Source Headline
15th Sep 20225:44 pmRNSHolding(s) in Company
7th Sep 20227:00 amRNSDirector/PDMR Share Dealing
30th Aug 20224:52 pmRNSHolding(s) in Company
23rd Aug 20225:02 pmRNSHolding(s) in Company
18th Aug 20227:00 amRNSInterim Results
11th Aug 20223:31 pmRNSResult of AGM
11th Jul 20221:19 pmRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20222:26 pmRNSDirector/PDMR Dealing
29th Jun 202212:37 pmRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Final Results
7th Jun 20224:38 pmRNSHolding(s) in Company
31st May 202211:14 amRNSHolding(s) in Company
17th May 20225:41 pmRNSChange to Publication Date of Results
27th Apr 20227:00 amRNSQ1 Trading Update and Notice of Results
31st Mar 20224:17 pmRNSDirector/PDMR Share Dealing
18th Mar 202210:09 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSDirector/PDMR Share Dealing
1st Feb 20227:00 amRNSFull Year Trading Update
24th Jan 20227:00 amRNSHolding(s) in Company
11th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20227:00 amRNSAllotment of shares
24th Dec 20218:14 amRNSDirector/PDMR Share Dealing
23rd Dec 20217:00 amRNSAcquisition of Ego Eyewear
8th Dec 20217:00 amRNSAcquisition of BoDe
28th Oct 20217:00 amRNSQ3 Trading Update
20th Oct 20215:13 pmRNSHolding(s) in Company
8th Sep 20217:00 amRNSInterim Results
13th Aug 20217:00 amRNSNotice of Results
19th Jul 202111:42 amRNSResult of AGM
25th Jun 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20217:00 amRNSDirector/PDMR Dealing
18th Jun 20217:00 amRNSFinal Results
29th Apr 20217:00 amRNSQ1 Trading Update & Notice of Results
26th Feb 20217:00 amRNSDirector/PDMR LTIP Awards
8th Feb 20215:57 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFull Year Trading Update
13th Jan 20218:25 amRNSHolding(s) in Company
23rd Dec 20204:21 pmRNSDirector/PDMR LTIP Awards
11th Dec 20201:05 pmRNSHolding(s) in Company
11th Dec 202012:00 pmRNSHolding(s) in Company
11th Dec 202011:58 amRNSDirector/PDMR Share Dealings
10th Dec 20203:11 pmRNSEschenbach Acquisition satisfaction of condition
7th Dec 20201:01 pmRNSResult of General Meeting
20th Nov 20207:00 amRNSPublication of Circular and Notice of GM
19th Nov 20202:05 pmRNSResult of Placing and Total Voting Rights
19th Nov 20207:00 amRNSProposed Placing
19th Nov 20207:00 amRNSProposed Acquisition of Eschenbach Holding GmbH
14th Oct 20201:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.